Innoforce Pharmaceuticals
Manufacturing · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2277 Research Blvd Ste 250, Rockville, M...Phone Number
(224) 430-0311Website
www.innoforcepharma.comRevenue
$8.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Innoforce Pharmaceuticals
Innoforce is a partnership-focused biopharmaceutical company established to enable and accelerate the innovation of breakthrough medicines. The company has world-class biopharmaceutical manufacturing and development capabilities to serve global markets at the company's campus in Hangzhou, China, and offices in Rockville, Maryland. Innoforce offers end-to-end contract development and manufacturing service (CDMO), including GMP manufacturing of plasmid DNA, RNA, viral vector, and cell products by the middle of 2018. In addition, through a joint venture with a leading international supplier of life sciences products & services, the company provides CDMO services for antibody and protein drugs. Innoforce's enabling capabilities for incubating and developing cell, gene, and advanced biological therapies can support partners and portfolio companies to rapidly and efficiently bring cutting-edge treatments that impact patients' lives worldwide.Explore more
Innoforce Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Innoforce Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Innoforce Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Innoforce Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Innoforce Pharmaceuticals
Check if Innoforce Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Innoforce Pharmaceuticals is spiking on competitors!
Innoforce Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Innoforce Pharmaceuticals launches new products
Earning: See what the market has to say on Innoforce Pharmaceuticals recently announced quarterly report
Recommended Actions
Find VP level buyers at Innoforce Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Innoforce Pharmaceuticals
Compare insights from companies similar to Innoforce Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Innoforce Pharmaceuticals
$8.4M
51-200
Private
$156.6M
2018
MH
Michael HuangCMC Management Vice President, Quality
Company Profile Activity
Activity Insights
Innoforce Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Innoforce Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Innoforce Pharmaceuticals.
Innoforce Pharmaceuticals financials insights
Gather financial insights about Innoforce Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$156.6M
Innoforce Pharmaceuticals Tech Stack
A closer look at the technologies used by Innoforce Pharmaceuticals
Most Recent Scoops
Open Position
Lateral Move
Executive Move
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Facilities Management
Partnership
Integration, Partnership
Innoforce Pharmaceuticals News & Media
Innoforce Completes Second Tranche of Series A Financing
HANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Innoforce ("INF"), a biopharmaceutical manufacturing & development company, announced today the completion of a 1 billion CNY ($156.6M) Series A financing, with the closing of an additional 375M CNY ($58.7M) following the first tranche of 625M...Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China
HANGZHOU, China and ROCKVILLE, Md., Aug. 17, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), a biopharmaceutical innovation and partnership company, today announces that it has opened a new Advanced Cell and Gene Therapy Development Facility in Hangzhou, China. Analytical development (AD) and Process development (PD) represents a critical step towards providing services for potential clients in their cell & gene therapy product development to support clinical trials and further comInnoforce Pharmaceuticals to Participate in BIO International Digital Convention
HANGZHOU, China and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), an innovation and partnership-focused biopharmaceutical company, today announces that the company is participating in the BIO International Digital Convention (BIO Digital) being held...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Innoforce Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Innoforce is a partnership-focused biopharmaceutical company established to enable and accelerate the innovation of breakthrough medicines. The company has world-class biopharmaceutical manufacturing and development capabilities to serve global markets at the company's campus in Hangzhou, China, and offices in Rockville, Maryland. Innoforce offers... Read More
